Indirect regulation of PCSK9 gene in inflammatory response by Porphyromonas gingivalis infection
- PMID: 30671557
- PMCID: PMC6328067
- DOI: 10.1016/j.heliyon.2018.e01111
Indirect regulation of PCSK9 gene in inflammatory response by Porphyromonas gingivalis infection
Erratum in
-
Corrigendum to "Indirect regulation of PCSK9 gene in inflammatory response by Porphyromonas gingivalis infection" [Heliyon 5 (1) (January 2019) e01111].Heliyon. 2019 Feb 18;5(2):e01210. doi: 10.1016/j.heliyon.2019.e01210. eCollection 2019 Feb. Heliyon. 2019. PMID: 30828655 Free PMC article.
Abstract
Pro-protein convertase subtilisin/kexin type 9 (PCSK9), a secreted serine protease, regulates serum low-density lipoprotein (LDL) cholesterol levels by targeting the degradation of LDL receptor (LDLR) in the liver. Although previous reports describe elevated levels of PCSK9 in patients with periodontitis, the mechanisms that trigger this increase in serum PCSK9 levels and induce the related inflammatory response remain unclear. In an unc93b1-deficient mouse of Porphyromonas gingivalis infection, nucleic acid antigen recognition via Toll-like receptors was found to promote PCSK9 production, suggesting an indirect role for tumor necrosis factor-α as an inducer of PCSK9 in contrast to that reported in previous studies. Furthermore, PCSK9 production was independent of the TIR domain-containing adapter-inducing interferon-β-dependent signaling pathway. These results indicate that changes in LDLR expression precede an increase in the serum PCSK9 level in the context of an infectious disease such as periodontitis.
Keywords: Immunology.
Figures




Similar articles
-
Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1171-8. doi: 10.1161/ATVBAHA.113.302670. Epub 2014 Mar 27. Arterioscler Thromb Vasc Biol. 2014. PMID: 24675665
-
Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration.Clin Chim Acta. 2012 Jan 18;413(1-2):154-9. doi: 10.1016/j.cca.2011.09.023. Epub 2011 Oct 6. Clin Chim Acta. 2012. PMID: 22001517
-
β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells.FEBS J. 2015 Jul;282(14):2682-96. doi: 10.1111/febs.13309. Epub 2015 May 18. FEBS J. 2015. PMID: 25913303 Free PMC article.
-
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23973703 Review.
-
Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy.Drugs Context. 2017 Nov 22;6:212511. doi: 10.7573/dic.212511. eCollection 2017. Drugs Context. 2017. PMID: 29209403 Free PMC article. Review.
Cited by
-
Roles of PCSK9 in the Pathogenesis of Periodontal Disease.Curr Med Chem. 2024;31(39):6429-6435. doi: 10.2174/0929867331666230809100021. Curr Med Chem. 2024. PMID: 37559246 Review.
-
Proprotein convertase subtilisin/kexin type 9 is a psoriasis-susceptibility locus that is negatively related to IL36G.JCI Insight. 2022 Aug 22;7(16):e141193. doi: 10.1172/jci.insight.141193. JCI Insight. 2022. PMID: 35862195 Free PMC article.
References
-
- Yokoyama C., Wang X., Briggs M.R., Admon A., Wu J., Hua X. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75(1):187–197. PubMed PMID: 8402897. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous